GABA-glutamate Interactions and Psychosis



Status:Recruiting
Conditions:Cognitive Studies
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:21 - 45
Updated:6/29/2018
Start Date:January 2007
End Date:December 2019
Contact:Uma Dieffenbach, BA
Email:uma.dieffenbach@yale.edu
Phone:203 932 5711

Use our guide to learn which trials are right for you!

Contribution of Gabaergic and Glutamatergic Mechanisms to Cognitive Dysfunction

This study investigates the interactions between NMDA (N-Methyl-D-aspartic acid) antagonism
and GABA (gamma-aminobutyric acid) system as it relates to cognitive function assessed by
ERPs (event-related potentials) in healthy volunteers.


Inclusion criteria:

- Ages of 21-45 years from all ethnic backgrounds.

- Male or female.

- Written informed consent.

Exclusion criteria:

- DSM-IV diagnosis for a psychotic, depressive or anxiety disorder.

- A history of significant medical/neurological disease such as cardiac, thyroid, renal,
hepatic abnormality, seizure disorder. Unstable medical condition based on EKG, vital
signs, physical examination and laboratory work-up (CBC with differential, SMA-7,
LFTs, TFTs, UA, Utox).

- History of abnormal EEG.

- History of severe allergies or multiple adverse drug reactions.

- Any medication that could interfere with either the safety of the study and/or the
outcome measures.

- Any other conditions which in the opinion of the investigator would preclude
participation in the study.

- History of major psychiatric disorder in first degree relatives.

- Current substance abuse/dependency determined by urine toxicology.

- Treatment with medications with CNS effects.

- Treatment with benzodiazepines within one week prior to testing.

- Current treatment with medications with psychotropic effects.

- Education < 10th grade.

- IQ < 70, MR.

- Non-English speaking.
We found this trial at
1
site
West Haven, Connecticut 06516
Phone: 203-932-5711
?
mi
from
West Haven, CT
Click here to add this to my saved trials